The DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
Abstract
The induction of hypoxia-inducible factor 1 (HIF-1) activity, either as a result of intratumoral hypoxia or loss-of-function mutations in the VHL gene, leads to a dramatic reprogramming of cancer cell metabolism involving increased glucose transport into the cell, increased conversion of glucose to pyruvate, and a concomitant decrease in mitochondrial metabolism and mitochondrial mass. Blocking these adaptive metabolic responses to hypoxia leads to cell death due to toxic levels of reactive oxygen species. Targeting HIF-1 or metabolic enzymes encoded by HIF-1 target genes may represent a novel therapeutic approach to cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HIF-1α also activates metabolic genes, such as PGK-1 and PFK1A, which increase glycolysis for ATP production during hypoxia (Semenza, 2009).”
From SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production (2011) · cites this paper as Semenza, 2009
Citations
Cites
1 retracted
Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., Gonzalez, F. J., & Semenza, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800102200 · Cited by 1,601
Self-citationRetractedTargeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Self-citationWang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Self-citationJaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Self-citationEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Self-citation
Cited by
Sorted by citations
Items 201–300 of 475
CD133 glycosylation is enhanced by hypoxia in cultured glioma stem cells
Lehnus, K. S., Donovan, L., Huang, X., Zhao, N., Warr, T. J., Pilkington, G. J., & An, Q. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1787 · Cited by 42
Artificial neural network classifier predicts neuroblastoma patients’ outcome
Cangelosi, D., Pelassa, S., Morini, M., Conte, M., Bosco, M. C., Eva, A., Sementa, A. R., & Varesio, L. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1194-3 · Cited by 42
Inhibition of miR-135b by SP-1 promotes hypoxia-induced vascular endothelial cell injury via HIF-1α
Yang, S., Yin, J. Y., & Hou, X. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.06.001 · Cited by 41
Offer, S., Menard, J. A., Pérez, J. E., de Oliveira, K. G., Chandran, V. I., Johansson, M. C., Bång-Rudenstam, A., Siesjö, P., Ebbesson, A., Hedenfalk, I. A., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1228-6 · Cited by 41
Role of Carcinoma-Associated Fibroblasts and Hypoxia in Tumor Progression
Giaccia, A. J., & Schipani, E. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_73 · Cited by 43
Gore, M., Kabekkodu, S. P., & Chakrabarty, S. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189292 · Cited by 41
Anti-Warburg effect of rosmarinic acid via miR-155 in colorectal carcinoma cells
Xu, Y., Han, S., Lei, K., Chang, X., Wang, K., Zhou, L., & Liu, J. (2015) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000205 · Cited by 39
A metabolic perspective of Peto's paradox and cancer
Dang, C. V. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0223 · Cited by 39
Relationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancer
Ulivi, P., Marisi, G., & Passardi, A. (2016) · Oncotarget · doi:10.18632/oncotarget.8712 · Cited by 40
Luo, S.-Y., 宁波大学海洋学院教育部应用海洋生物技术重点实验室, 浙. 宁. 3., Wang, J., Liu, C., Gao, X., Zhang, Y., Ding, J., Hou, C.-C., Zhu, J., Lou, B., et al. (2021) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2021.224 · Cited by 39
Bosello-Travain, V., Forman, H. J., Roveri, A., Toppo, S., Ursini, F., Venerando, R., Warnecke, C., Zaccarin, M., & Maiorino, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.12.020 · Cited by 38
Hypoxia as a Cause of Treatment Failure in Non–Small Cell Carcinoma of the Lung
Brustugun, O. T. (2014) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2014.11.006 · Cited by 38
Renal cell carcinoma: translational aspects of metabolism and therapeutic consequences
Yang, O. C. Y., Maxwell, P. H., & Pollard, P. J. (2013) · Kidney International · doi:10.1038/ki.2013.245 · Cited by 38
Normoxic accumulation of HIF1α is associated with glutaminolysis
Kappler, M., Pabst, U., Rot, S., Taubert, H. W., Wichmann, H., Schubert, J., Bache, M., Weinholdt, C., Immel, U., Große, I., et al. (2016) · Clinical Oral Investigations · doi:10.1007/s00784-016-1780-9 · Cited by 38
The Roles of HIF-1α in Radiosensitivity and Radiation-Induced Bystander Effects Under Hypoxia
Zhang, J., Zhang, Y., Mo, F., Patel, G., Butterworth, K. T., Shao, C., & Prise, K. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.637454 · Cited by 38
Abreu, P. L., Ferreira, L. M. R., Alpoim, M. C., & Urbano, A. M. (2014) · BioMetals · doi:10.1007/s10534-014-9726-7 · Cited by 39
Zhu, Y., Zhao, T., Itasaka, S., Li, Z., Yeom, C. J., Hirota, K., Suzuki, K., Morinibu, A., Shinomiya, K., Ou, G., et al. (2012) · Oncogene · doi:10.1038/onc.2012.223 · Cited by 38
Kuchimaru, T., Kadonosono, T., Tanaka, S., Ushiki, T., Hiraoka, M., & Kizaka‐Kondoh, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015736 · Cited by 37
Metabolic Reprogramming in Cancer: Role of HPV 16 Variants
Arizmendi-Izazaga, A., Navarro‐Tito, N., Jiménez‐Wences, H., Catalán, M. A. M., Martínez-Carrillo, D. N., Zacapala-Gómez, A. E., Olea‐Flores, M., Dircio-Maldonado, R., Torres‐Rojas, F. I., Soto-Flores, D. G., et al. (2021) · Pathogens · doi:10.3390/pathogens10030347 · Cited by 37
Vosloo, D., Sara, J. R., & Vosloo, A. (2011) · Aquatic Toxicology · doi:10.1016/j.aquatox.2011.10.001 · Cited by 37
Penet, M., Pathak, A. P., Raman, V., Ballesteros, P., Artemov, D., & Bhujwalla, Z. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1782 · Cited by 37
Manipulation of Glycolysis in Malignant Tumors: Fantasy or Therapy?
Sattler, U. G. A., Hirschhaeuser, F., & Mueller-Klieser, W. (2009) · Current Medicinal Chemistry · doi:10.2174/092986710790112657 · Cited by 37
Metabolic pathways fueling the suppressive activity of myeloid-derived suppressor cells
Goldmann, O., & Medina, E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1461455 · Cited by 42
Bock, K. D., Smet, F. D., de Oliveira, R. L., Anthonis, K., & Carmeliet, P. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0482-z · Cited by 39
Furuta, C., Miyamoto, T., Takagi, T., Noguchi, Y., Kaneko, J., Itoh, S., Watanabe, T., & Itoh, F. (2015) · Cancer Science · doi:10.1111/cas.12773 · Cited by 37
Scatena, R., Bottoni, P., Pontoglio, A., & Giardina, B. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900157 · Cited by 36
Maugeri, G., D’Amico, A. G., Reitano, R., Saccone, S., Federico, C., Cavallaro, S., & D’Agata, V. (2016) · Cell and Tissue Research · doi:10.1007/s00441-015-2340-3 · Cited by 35
Cheng, W., Cheng, Z., Weng, L., Xing, D., & Zhang, M. (2021) · Journal of Cancer · doi:10.7150/jca.51407 · Cited by 36
Kuzmanov, A., Wielockx, B., Rezaei, M., Kettelhake, A., & Breier, G. (2011) · International Journal of Cancer · doi:10.1002/ijc.27360 · Cited by 36
Mangiavini, L., Merceron, C., Araldi, E., Khatri, R., Gerard-O’Riley, R. L., Wilson, T. L., Rankin, E. B., Giaccia, A. J., & Schipani, E. (2014) · Developmental Biology · doi:10.1016/j.ydbio.2014.06.013 · Cited by 36
Reactive oxygen species in BCR-ABL1-expressing cells – relevance to chronic myeloid leukemia
Antoszewska-Smith, J., Pawłowska, E., & Błasiak, J. (2016) · Acta Biochimica Polonica · doi:10.18388/abp.2016_1396 · Cited by 36
Kobliakov, V. A. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919100018 · Cited by 34
Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients
Cangelosi, D., Blengio, F., Versteeg, R., Eggert, A., Garaventa, A., Gambini, C., Conte, M., Eva, A., Muselli, M., & Varesio, L. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-s7-s12 · Cited by 34
Logghe, T., van Zwol, E., Immordino, B., den Cruys, K. V., Peeters, M., Giovannetti, E., & Bogers, J. (2024) · Cancers · doi:10.3390/cancers16030505 · Cited by 37
The Diverse Roles of Histone Demethylase KDM4B in Normal and Cancer Development and Progression
Wang, Z., Cai, H., Zhao, E., & Cui, H. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.790129 · Cited by 33
Functional regulation of hypoxia inducible factor-1α by SET9 lysine methyltransferase
Liu, Q., Geng, H., Xue, C., Beer, T. M., & Qian, D. Z. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.01.011 · Cited by 32
Differential response to exercise in claudin-low breast cancer
Glass, O. K., Bowie, M., Fuller, J., Darr, D., Usary, J., Boss, K., Choudhury, K. R., Liu, X., Zhang, Z., Locasale, J. W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21054 · Cited by 32
Blue-Print Autophagy: Potential for Cancer Treatment
Ruocco, N., Costantini, S., & Costantini, M. (2016) · Marine Drugs · doi:10.3390/md14070138 · Cited by 33
Hypoxia-induced PGC-1α Regulates Mitochondrial Function and Tumorigenesis of Colorectal Cancer Cells
Yun, C. W., Lee, J. H., & Lee, S. H. (2019) · Anticancer Research · doi:10.21873/anticanres.13672 · Cited by 32
Expression of asporin reprograms cancer cells to acquire resistance to oxidative stress
Sasaki, Y., Takagane, K., Konno, T., Itoh, G., Kuriyama, S., Yanagihara, K., Yashiro, M., Yamada, S., Murakami, S., & Tanaka, M. (2021) · Cancer Science · doi:10.1111/cas.14794 · Cited by 33
HIF-Dependent Mechanisms of Relationship between Hypoxia Tolerance and Tumor Development
Dzhalilova, D. S., & Makarova, O. V. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921100011 · Cited by 34
Cangelosi, D., Muselli, M., Parodi, S., Blengio, F., Becherini, P., Versteeg, R., Conte, M., & Varesio, L. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-s5-s4 · Cited by 32
Bi, L., Yang, L., Yang, Q., Zhou, X., Li, H., Yang, L., Li, J., Lu, Y., & Tang, H. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4863 · Cited by 31
Choi, H., Hexiu, J., Kim, J., Lim, K., Choung, H., Park, J., Chung, J. H., & Choung, P. (2013) · Tissue Engineering Part A · doi:10.1089/ten.tea.2013.0132 · Cited by 31
Flores, R. E., Brown, A. K., Taus, L. J., Khoury, J., Glover, F., Kami, K., Sarangarajan, R., Walshe, T. E., Narain, N. R., Kiebish, M. A., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2018.03.012 · Cited by 31
van Gisbergen, M. W., Offermans, K., Voets, A. M., Lieuwes, N. G., Biemans, R., Hoffmann, R. F., Dubois, L. J., & Lambin, P. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00770 · Cited by 30
Lee, H., Jung, D., Sohn, E. J., Kim, H. H., Park, M. N., Lew, J.-H., Lee, S., Kim, B., & Kim, S. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/390957 · Cited by 30
1H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism
Čuperlović‐Culf, M., Cormier, K., Touaibia, M., Reyjal, J., Robichaud, S., Belbraouet, M., & Turcotte, S. (2015) · International Journal of Cancer · doi:10.1002/ijc.29947 · Cited by 31
Myristica fragransSuppresses Tumor Growth and Metabolism by Inhibiting Lactate Dehydrogenase A
Kim, E.-Y., Choi, H., Park, M.-J., Jung, Y.-S., Lee, S., Kim, K., Choi, J., Chung, T., & Ha, K. (2016) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x16500592 · Cited by 30
Szulc, A., & Woźniak, M. (2024) · Cancers · doi:10.3390/cancers16081483 · Cited by 32
Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer
Durán, R., Mirpour, S., Pekurovsky, V., Ganapathy‐Kanniappan, S., Brayton, C. F., Cornish, T. C., Gorodetski, B., Reyes, J., Chapiro, J., Schernthaner, R. E., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0725 · Cited by 29
Modelling pyruvate dehydrogenase under hypoxia and its role in cancer metabolism
Eyassu, F., & Angione, C. (2017) · Royal Society Open Science · doi:10.1098/rsos.170360 · Cited by 30
Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance
Sahami-Fard, M. H., Kheirandish, S., & Sheikhha, M. H. (2019) · Cancer Biomarkers · doi:10.3233/cbm-182171 · Cited by 29
Sasajima, J., Mizukami, Y., Sugiyama, Y., Nakamura, K., Kawamoto, T., Koizumi, K., Fujii, R., Motomura, W., Sato, K., Suzuki, Y., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0412 · Cited by 29
Kim, D. H., Hossain, M. A., KIM, M. Y., KIM, J.-A., Yoon, J.-H., Suh, H. S., Kim, G., Choi, Y. H., Chung, H. Y., & Kim, N. D. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2116 · Cited by 29
She, W., Liu, T., Li, H., Wang, Z., Guo, Z., Liu, Y., & Liu, Y. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01197 · Cited by 28
Liu, R., Wang, X., Shen, Y., & He, A. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06247-7 · Cited by 28
The Ketogenic Diet in Colorectal Cancer: A Means to an End
Tamraz, M., Ghossaini, N. A., & Temraz, S. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043683 · Cited by 28
Oxygen Sensing: A Common Crossroad in Cancer and Neurodegeneration
Quaegebeur, A., & Carmeliet, P. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_83 · Cited by 27
Jang, S. M., Han, H., Jang, K.-S., Jun, Y. J., Jang, S., Min, K., Chung, M. S., & Paik, S. S. (2012) · Journal of Breast Cancer · doi:10.4048/jbc.2012.15.2.172 · Cited by 28
Chen, X., Yang, M. Y., Hao, W., Han, J., Ma, J., Wang, C., Sun, S., & Zheng, Q. (2016) · Gene · doi:10.1016/j.gene.2016.07.052 · Cited by 28
Fueled by microtubules: Does tubulin dimer/polymer partitioning regulate intracellular metabolism?
Cassimeris, L., Silva, V. C., Miller, E., Ton, Q. V., Molnar, C. A., & Fong, J. T. (2012) · Cytoskeleton · doi:10.1002/cm.21008 · Cited by 30
Jones, D. T., Valli, A., Haider, S. A., Zhang, Q., Smethurst, E. A., Schug, Z. T., Peck, B., Aboagye, E. O., Critchlow, S. E., Schulze, A., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0857 · Cited by 26
Prognostic Impacts of Hypoxic Markers in Soft Tissue Sarcoma
Smeland, E., Kilvaer, T. K., Sørbye, S. W., Valkov, A., Andersen, S., Bremnes, R. M., Busund, L., & Dønnem, T. (2012) · Sarcoma · doi:10.1155/2012/541650 · Cited by 27
Iron deficiency modifies gene expression variation induced by augmented hypoxia sensing
Zhang, X., Zhang, W., Ma, S., Miasniakova, G., Sergueeva, A., Ammosova, T., Xu, M., Nekhai, S. A., Nourai, M., Wade, M. S., et al. (2013) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.07.016 · Cited by 26
Zhang, Q., Qin, Y., Sun, X., Bian, Z., Liu, H., Liu, H., Mao, L., & Sun, S. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111227 · Cited by 33
Hypoxia-inducible-factor-1 in trauma and critical care
Bogdanovski, D. A., DiFazio, L. T., Bogdanovski, A. K., Csóka, B., Jordan, G. B., Paul, E. R., Antonioli, L., Pilip, S. A., & Németh, Z. H. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.07.029 · Cited by 26
Forchlorfenuron Disrupts SEPT9_i1 Filaments and Inhibits HIF-1
Vardi‐Oknin, D., Golan, M., & Mabjeesh, N. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073179 · Cited by 26
Yeom, C. J., Zeng, L., Zhu, Y., Hiraoka, M., & Harada, H. (2011) · Cancers · doi:10.3390/cancers3033610 · Cited by 26
Straud, S., Zubovych, I. O., Brabander, J. K. D., & Roth, M. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011629 · Cited by 26
Wan, X., Liu, Y., Zhao, Y., Sun, X., Fan, D., & Guo, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184213 · Cited by 27
Kokkonen, N., Khosrowabadi, E., Hassinen, A., Harrus, D., Glumoff, T., Kietzmann, T., & Kellokumpu, S. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7389 · Cited by 26
Manley, S., Liu, W., & Welch, D. R. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1552-2 · Cited by 26
Bioactive food components, cancer cell growth limitation and reversal of glycolytic metabolism
Keijer, J., Bekkenkamp‐Grovenstein, M., Venema, D. P., & Dommels, Y. E. M. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.08.007 · Cited by 25
Fox, S. B., Generali, D., Berruti, A., Brizzi, M. P., Campo, L., Bonardi, S., Bersiga, A., Allevi, G., Milani, M., Aguggini, S., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2825 · Cited by 24
The estrogen-related receptors in metabolism and cancer: newer insights
Ranhotra, H. S. (2018) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2018.1456552 · Cited by 24
Kumar, A., Rathi, E., & Kini, S. G. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1626285 · Cited by 23
Shih, H.-J., Chang, H., Chen, C., & Torng, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-02400-1 · Cited by 23
Combined therapies of antithrombotics and antioxidants delayin silicobrain tumour progression
Martínez‐González, A., Durán‐Prado, M., Calvo, G. F., Alcain, F. J., Pérez-Romasanta, L. A., & Pérez‐García, V. M. (2014) · Mathematical Medicine and Biology A Journal of the IMA · doi:10.1093/imammb/dqu002 · Cited by 23
Solution-phase synthesis and biological evaluation of triostin A and its analogues
Hattori, K., Koike, K., Okuda, K., Hirayama, T., Ebihara, M., Takenaka, M., & Nagasawa, H. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob02505b · Cited by 23
Environmental and behavioral regulation of HIF-mitochondria crosstalk
Burtscher, J., Hohenauer, E., Burtscher, M., Millet, G. P., & Egg, M. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.06.015 · Cited by 27
Regulation of Glucose Metabolism in Hepatocarcinogenesis by MicroRNAs
Reyes, R., Motiwala, T., & Jacob, S. T. (2014) · Gene Expression · doi:10.3727/105221614x13919976902093 · Cited by 22
Impact of acetylation on tumor metabolism
Zhao, D., Li, F.-L., Cheng, Z., & Lei, Q. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.963452 · Cited by 24
Malamas, A. S., Jin, E., Gujrati, M. D., & Lu, Z. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00227 · Cited by 22
Zhang, L., Zhang, Y., Zhang, X., Zhang, Y., Jiang, Y., Xiao, X., Tan, J. Y., Yuan, W., & Liu, Y. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0853-1 · Cited by 23
Ichikawa, T., Aokage, K., Miyoshi, T., Tane, K., Suzuki, K., Makinoshima, H., Tsuboi, M., & Ishii, G. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.08.003 · Cited by 21
Kong, H., Lee, S., Beebe, K. E., Scroggins, B. T., Gupta, G. N., Lee, M.-J., Jung, Y., Trepel, J. B., & Neckers, L. Μ. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066514 · Cited by 20
Marushima, H. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1142 · Cited by 22
Kim, J. A., Kim, S. J., Do, I., Jin, J., Nam, D., Ko, Y. H., Kım, K., & Kim, W. S. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.542261 · Cited by 21
Metabolic Alterations During the Growth of Tumour Spheroids
Bloch, K. M., Smith, H., Parsons, V. V. H., Gavaghan, D. J., Kelly, M., Fletcher, A. G., Maini, P. K., & Callaghan, R. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9757-7 · Cited by 22
Cai, Z., Li, H., Zhang, H., Han, S., AN, R., & Yan, X. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1595 · Cited by 20
Tumor-initiating and metastasis-initiating cells of clear-cell renal cell carcinoma
Pham, D.-X., & Hsu, T. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-024-01111-9 · Cited by 25
Thomsen, K., Yokota, T., Hasan‐Olive, M. M., Dreyer, N. S., Fakouri, N. B., Desler, C., Regnell, C. E., Larsen, S., Rasmussen, L. J., Dela, F., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.08.004 · Cited by 20
p62 functions as a signal hub in metal carcinogenesis
Zhang, Z., & Costa, M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.014 · Cited by 21
Liu, Y., Cai, F., Liu, K., Liu, J., Zhang, X., & Yusufu, A. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.810723 · Cited by 20
An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3
Ramachandran, A., Betts, G. N. J., Bhana, S., Helme, G., Blick, C., Möller‐Levet, C. S., Saunders, E., Valentine, H. R., Pepper, S. D. V., Miller, C. J., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.003 · Cited by 20
Abbott, K. L., Ali, A., Reinfeld, B. I., Deik, A., Subudhi, S., Landis, M. D., Hongo, R. A., Young, K. L., Kunchok, T., Nabel, C. S., et al. (2024) · eLife · doi:10.7554/elife.95652 · Cited by 22
Effects of the silencing of hypoxia-inducible Factor-1 alpha on metastasis of pancreatic cancer.
Wei, H., Li, F., Fu, P., & Liu, X. (2013) · PubMed · Cited by 19
Chen, X., Luo, Z., Liu, X., Li, X., Li, Q., Zhang, W., Liu, Y., Cheng, Z., Yang, X. M., Liu, Y., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115381 · Cited by 19
Yaromina, A., Meyer, S. S., Fabian, C. G., Zaleska, K., Sattler, U. G. A., Kunz‐Schughart, L. A., Mueller-Klieser, W., Zips, D., & Baumann, M. A. (2012) · Strahlentherapie und Onkologie · doi:10.1007/s00066-011-0054-3 · Cited by 19
Metadata
- Authors
- Semenza, G. L.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Semenza, Gregg L.
- ORCID
- Semenza, Gregg L.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 19
- Issue
- 1
- Pages
- 12-16
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2102416115
- Cited by
- 469
- References
- 67
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 15 · 2023: 19 · 2022: 14 · 2021: 28 · 2020: 21 · 2019: 21 · 2018: 22 · 2017: 29 · 2016: 36 · 2015: 32 · 2014: 33 · 2013: 35 · 2012: 35
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Cancer Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- HIF-1, cancer metabolism, tumor hypoxia, VHL gene, glucose transport, glycolysis, mitochondrial metabolism, reactive oxygen species, HIF-1 target genes, metabolic reprogramming, cancer therapy
- MeSH terms
- Animals, Glycolysis, Humans, Neoplasms, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Hypoxia-Inducible Factor 1, Von Hippel-Lindau Tumor Suppressor Protein, Metabolic Networks and Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review